Effect of Lymphocyte/Monocyte Ratio on Clinical Features and Prognosis of Patients with Primary Gastrointestinal Diffuse Large B Cell Lymphoma / 中国实验血液学杂志

ABSTRACT

<p><b>OBJECTIVE</b>To analyze the effect of lymphocyte/monocyte ratio(LMR) on clinical features and prognosis of patients with primary gastrointestinal diffuse large B cell lymphoma(PGI-DLBCL).</p><p><b>METHODS</b>The clinical data of 38 PGI-DLBCL patients with complete follow-up data in our hospital were analyzed retrospectively. The absolute lymphocyte count(ALC), absolute monocyte count(AMC) and LMR were counted by automating complete blood cell count statistics in newly diagnosed patients, and then the LMR cut off value was obtained by ROC curve. All patients were divided into ≤3.9 group and >3.9 group according to cut off value.</p><p><b>RESULTS</b>Out of 38 patients 21 male and 17 female with a median age 55 old years (29-73 years), 7 cases died, the clinical B symptom occurred in 7 cases (18.4%); the pathologic type of 13 cases (34.2%) belonged to germinal center B-cell like, the primary gastral and intestinal DLBCL were observed in 18 and 20 cases respectively. The chisquare test showed that the LMR associated with of clinical stage and tumor size of PGI-DLBCL. The median survival time was 44 months (7-100 months), and 5-year overrall survival(OS) rate was 78.3% for 38 PGI-DLBCL cases. The univariate analysis showed that age (P=0.021), stage (P=0.012), IPI score (P=0.001), LDH level (P<0.001), tumor size (P=0.037) and LMR (P=0.026) all associate with the 5 years OS rate(%), and the difference was between them statistically significant, but the multivariate analysis showed that only clinical staging is independent risk factors for the OS.</p><p><b>CONCLUSION</b>LMR shows an important effect on clinical features and prognosis of PGI-DLBCL.</p>